{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:22Z","timestamp":1787169862510,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Erectile dysfunction (ED) is defined as the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance. Bypassing health-care providers and obtaining ED medications (EDM) without a prescription are an issue that is faced globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>We attempt to assess erectile function (EF) among a local sample of physicians, the psychological effects of recreational EDM use, and compare EF among different user groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This is a cross-sectional study done solely on physicians in Saudi Arabia. A self-designed questionnaire including demographics, sexual characteristics, use of ED medication, sexual satisfaction, and the validated international index of EF (IIEF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome:<\/jats:title>\n                    <jats:p>Physicians misused EDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 503 physicians completed the questionnaire. Among participants reporting sexual problems, only 23% received counseling and 3.4% were professionally diagnosed with ED. Among users, 71.2% were using EDM recreationally, 14.4% prophylactically, and 14.4% were prescribed. Participants aged 20\u201329 IIEF-5 score was significantly lower than participants aged 30\u201339 years. Prescribed users had a lower IIEF-5 score compared to both recreational users and nonusers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Implications:<\/jats:title>\n                    <jats:p>Many healthy sexually active men use EDMs recreationally to increase sexual performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths and Limitations:<\/jats:title>\n                    <jats:p>One of the limitations of our study is that we did not use standardized tools to determine the diagnosis of some important disorders like premature ejaculation. Our study strengths include the very high response rate, with our results truly showing a nationwide self-assessment of sexual dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Recreational use of oral EDMs may adversely impact the psychological aspects of sexual function. In our study, physicians misused EDM. We recommend labeling EDMs as restricted medication that requires a prescription to use by a licensed physician.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ua.ua_33_22","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T11:17:37Z","timestamp":1680866257000},"page":"148-157","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Recreational use of oral erectile dysfunction medications among male physicians - A cross-sectional study"],"prefix":"10.4103","volume":"15","author":[{"given":"Raed","family":"Almannie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meshari A","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Almuhaideb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abunohaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Habous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Binsaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20240828","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1038\/nrdp.2016.3","article-title":"Erectile dysfunction","volume":"2","author":"Yafi","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R3-4-20240828","first-page":"47","article-title":"Sildenafil:An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction","volume":"8","author":"Boolell","year":"1996","journal-title":"Int J Impot Res"},{"key":"R4-4-20240828","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1081\/CLT-100102015","article-title":"Sildenafil:Clinical toxicology profile","volume":"38","author":"Krenzelok","year":"2000","journal-title":"J Toxicol Clin Toxicol"},{"key":"R6-4-20240828","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/bph.14205","article-title":"PDE5 inhibitors \u2013Pharmacology and clinical applications 20 years after sildenafil discovery","volume":"175","author":"Andersson","year":"2018","journal-title":"Br J Pharmacol"},{"key":"R7-4-20240828","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1743-6109.2009.01674.x","article-title":"Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors","volume":"7","author":"Schnetzler","year":"2010","journal-title":"Sex Med"},{"key":"R8-4-20240828","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12199-010-0134-5","article-title":"Economic analysis of use of counterfeit drugs:Health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example","volume":"15","author":"Sugita","year":"2010","journal-title":"Environ Health Prev Med"},{"key":"R9-4-20240828","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1743-6109.2012.02728.x","article-title":"Profiling characteristics of men who use phosphodiesterase type 5 inhibitors based on obtaining patterns:Data from the nationwide Japanese population","volume":"9","author":"Kimura","year":"2012","journal-title":"J Sex Med"},{"key":"R10-4-20240828","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM199910283411810","article-title":"Direct sale of sildenafil (Viagra) to consumers over the internet","volume":"341","author":"Armstrong","year":"1999","journal-title":"N Engl J Med"},{"key":"R11-4-20240828","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1742-1241.2009.02328.x","article-title":"Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks","volume":"64","author":"Jackson","year":"2010","journal-title":"Int J Clin Pract"},{"key":"R12-4-20240828","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1111\/j.1743-6109.2010.01965.x","article-title":"Recreational use of phosphodiesterase type 5 inhibitors by healthy young men","volume":"7","author":"Bechara","year":"2010","journal-title":"Sex Med"},{"key":"R13-4-20240828","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3844\/ajidsp.2006.107.114","article-title":"Recreational viagra use and sexual risk among drug abusing men","volume":"2","author":"Fisher","year":"2006","journal-title":"Am J Infect Dis"},{"key":"R14-4-20240828","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/j.1743-6109.2012.02755.x","article-title":"Recreational use of erectile dysfunction medications and its adverse effects on erectile function in young healthy men:The mediating role of confidence in erectile ability","volume":"9","author":"Harte","year":"2012","journal-title":"Sex Med"},{"key":"R15-4-20240828","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.ijir.3901584","article-title":"Recreational use of erectile dysfunction medication may decrease confidence in ability to gain and hold erections in young males","volume":"19","author":"Santtila","year":"2007","journal-title":"Int J Impot Res"},{"key":"R16-4-20240828","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"R17-4-20240828","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1743-6109.2006.00287.x","article-title":"Subclinical erectile dysfunction:Proposal for a novel taxonomic category in sexual medicine","volume":"3","author":"Jannini","year":"2006","journal-title":"J Sex Med"},{"key":"R18-4-20240828","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1331\/1544345052843165","article-title":"Recreational use and misuse of phosphodiesterase 5 inhibitors","volume":"45","author":"Smith","year":"2005","journal-title":"Am Pharm Assoc"},{"key":"R19-4-20240828","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1743-6109.2008.00792.x","article-title":"Recreational use of PDE5 inhibitors by young healthy men:Recognizing this issue among medical students","volume":"5","author":"Korkes","year":"2008","journal-title":"Sex Med"},{"key":"R20-4-20240828","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41443-019-0170-7","article-title":"The impact of burnout and occupational stress on sexual function in both male and female individuals:A cross-sectional study","volume":"32","author":"Papaefstathiou","year":"2020","journal-title":"Int J Impot Res"},{"key":"R21-4-20240828","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1743-6109.2007.00744.x","article-title":"The sexual lives of medical students:A single institution survey","volume":"5","author":"Shindel","year":"2008","journal-title":"Sex Med"},{"key":"R22-4-20240828","doi-asserted-by":"crossref","first-page":"e0206840","DOI":"10.1371\/journal.pone.0206840","article-title":"Burnout syndrome among medical residents:A systematic review and meta-analysis","volume":"13","author":"Rodrigues","year":"2018","journal-title":"PLoS One"},{"key":"R23-4-20240828","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1742-1241.2008.01845.x","article-title":"Stress, workload, sexual well-being and quality of life among physician residents in training","volume":"63","author":"Sangi-Haghpeykar","year":"2009","journal-title":"Int J Clin Pract"},{"key":"R24-4-20240828","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1001\/jama.1991.03460160052028","article-title":"Substance use among senior medical students:A survey of 23 medical schools","volume":"265","author":"Baldwin","year":"1991","journal-title":"J Am Med Assoc"},{"key":"R25-4-20240828","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0022-4804(92)90046-3","article-title":"The stresses of the surgical residency","volume":"53","author":"Bunch","year":"1992","journal-title":"Surg Res"},{"key":"R26-4-20240828","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1743-6109.2011.02297.x","article-title":"The global online sexuality survey (GOSS):Erectile dysfunction among Arabic-speaking internet users in the Middle East","volume":"8","author":"Shaeer","year":"2011","journal-title":"Sex Med"},{"key":"R27-4-20240828","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1743-6109.2012.02972.x","article-title":"The Global Online Sexuality Survey (GOSS):The United States of America in 2011 Chapter II:Phosphodiesterase inhibitors utilization among English speakers","volume":"10","author":"Shaeer","year":"2013","journal-title":"Sex Med"},{"key":"R28-4-20240828","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.ijir.3901005","article-title":"Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time","volume":"15","author":"Mondaini","year":"2003","journal-title":"Int J Impot Res"},{"key":"R29-4-20240828","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/humrep\/15.1.131","article-title":"Effects of sildenafil (Viagra\u2122) administration on seminal parameters and post-ejaculatory refractory time in normal males","volume":"15","author":"Aversa","year":"2000","journal-title":"Hum Reprod"},{"key":"R30-4-20240828","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0090-4295(03)00131-6","article-title":"Nitric oxide and the lower urinary tract:Current concepts, future prospects","volume":"61","author":"Mamas","year":"2003","journal-title":"Urology"},{"key":"R31-4-20240828","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","article-title":"Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation:A systematic review","volume":"98","author":"McMahon","year":"2006","journal-title":"BJU Int"},{"key":"R32-4-20240828","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/j.1743-6109.2011.02628.x","article-title":"Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation?A systematic review and meta-analysis","volume":"9","author":"Asimakopoulos","year":"2012","journal-title":"J Sex Med"},{"key":"R33-4-20240828","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.esxm.2017.10.003","article-title":"EDEUS, a real-life study on the users of phosphodiesterase type 5 inhibitors:Prevalence, perceptions, and health care-seeking behavior among European men with a focus on 2nd-generation avanafil","volume":"6","author":"Corona","year":"2018","journal-title":"Sex Med"},{"key":"R34-4-20240828","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10508-010-9619-y","article-title":"Recreational use of erectile dysfunction medications in undergraduate men in the United States:Characteristics and associated risk factors","volume":"40","author":"Harte","year":"2011","journal-title":"Arch Sex Behav"},{"key":"R35-4-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4197\/Med.15-2.3","article-title":"Use pattern of oral PDE-5 inhibitors in Jeddah, Saudi Arabia","volume":"15","author":"Alahdal","year":"2008","journal-title":"King Abdulaziz Univ Sci"},{"key":"R36-4-20240828","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.aju.2016.03.003","article-title":"Phosphodiesterase type 5 inhibitors:Irrational use in Saudi Arabia","volume":"14","author":"Alshahrani","year":"2016","journal-title":"Arab J Urol"},{"key":"R37-4-20240828","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.fertnstert.2006.11.017","article-title":"Sildenafil citrate improves sperm motility but causes a premature acrosome reaction in vitro","volume":"87","author":"Glenn","year":"2007","journal-title":"Fertil Steril"},{"key":"R38-4-20240828","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/bmj.318.7184.669","article-title":"Sildenafil (Viagra) is used as a recreational drug in England [6]","volume":"318","author":"Aldridge","year":"1999","journal-title":"Br Med J"},{"key":"R39-4-20240828","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3109\/10826084.2015.1013135","article-title":"Significant misuse of sildenafil in London nightclubs","volume":"50","author":"Chan","year":"2015","journal-title":"Subst Use Misuse"},{"key":"R40-4-20240828","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jsxm.2017.04.670","article-title":"Off-label use of phosphodiesterase type 5 inhibitor erectile dysfunction medication to enhance sex among gay and bisexual men in Australia:Results from the FLUX study","volume":"14","author":"Hammoud","year":"2017","journal-title":"Sex Med"},{"key":"R41-4-20240828","doi-asserted-by":"crossref","first-page":"e13364","DOI":"10.1111\/and.13364","article-title":"Study of the prevalence and patterns of phosphodiesterase type 5 inhibitor use among sexually active Egyptian males:A national cross-sectional survey","volume":"51","author":"Attia","year":"2019","journal-title":"Andrologia"}],"container-title":["Urology Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ua.ua_33_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:14Z","timestamp":1787166854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ua.ua_33_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ua.ua_33_22","relation":{},"ISSN":["0974-7796"],"issn-type":[{"value":"0974-7796","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}